U.S. Markets close in 3 hrs 10 mins

SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit Against OvaScience, Inc.


Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against OvaScience, Inc. (“OvaScience” or the “Company”) (OVAS). Investors who purchased or otherwise acquired shares between January 8, 2015 and March 26, 2015 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the May 26, 2017 lead plaintiff motion deadline.

If you are a shareholder who suffered a loss during the Class Period, click here to participate. In addition, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights free of charge. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The complaint alleges that during the Class Period, OvaScience issued false and misleading statements and/or failed to disclose that: the science behind AUGMENT, a treatment specifically designed to improve a patient’s egg health, had not been scientifically validated; that the Company was unable to achieve the purported success rates it claimed; and that at all relevant times, the Company’s profitability and prospects were false and misleading. When this news was announced, the stock price of OvaScience fell, causing investors harm.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170419006708/en/